(2S,3R)-4-(TERT-BUTOXYCARBONYL)-2-METHYLMORPHOLINE-3-CARBOXYLIC ACID, 95.0%, 250mg

1'-methyl-3,4-dihydrospiro[1-benzopyran-2,4'-piperidin]-4-one, 95.0%, 500mg

5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidine dihydrochloride, 95.0%, 25g

3-tert-Butyl-L-alanine, 97.0%, 250mg

3-(Trifluoroacetyl)indole>98.0%(GC)1g

Sample beakers with screw closure with graduation and labelling area, 120 ml, Sterile, 250 Piece(s)

Hexanohydroxamic Acid, 98.0%, 1g

1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(propan-2-yl)methanimidamide, 97%, 5g

ethyl 4-(3,4-dimethoxyphenyl)-3-oxobutanoate, 95.0%, 2g

2-(2-Chloro-5-nitrophenoxy)acetic acid, 98%, 10g

2-Chloro-5-nitropyridine>99.0%(GC)5g

4-[2,2,2-Trifluoro-1-[(trimethylsilyl)oxy]ethyl]morpholine>95.0%(GC)5g

5-Bromo-2-methylindole, 98.0%, 5g